about
Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic CancerNovel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinomaQuercetin-induced miR-200b-3p regulates the mode of self-renewing divisions in pancreatic cancerLong noncoding RNA MALAT-1 enhances stem cell-like phenotypes in pancreatic cancer cellsIGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic CancerDownstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in human pancreatic cancer.Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia.T cell optimization for the treatment of pancreatic cancer.Matrix control of pancreatic cancer: New insights into fibronectin signalingAutocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.Epigenetic control of the tumor microenvironment.Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer.Matrix stiffness induces epithelial-mesenchymal transition and promotes chemoresistance in pancreatic cancer cells.Chemoresistance in pancreatic cancer: Emerging conceptsAntifibrotic effects of pentoxifylline improve the efficacy of gemcitabine in human pancreatic tumor xenografts.CD44 Expression Level and Isoform Contributes to Pancreatic Cancer Cell Plasticity, Invasiveness, and Response to Therapy.Differentiation of benign and malignant solid pancreatic masses using magnetic resonance elastography with spin-echo echo planar imaging and three-dimensional inversion reconstruction: a prospective study.Norleual, a hepatocyte growth factor and macrophage stimulating protein dual antagonist, increases pancreatic cancer sensitivity to gemcitabine.Experimental models of pancreatic cancer desmoplasia.Role of TRPC1 channels in pressure-mediated activation of murine pancreatic stellate cells.The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma.Feasibility of magnetic resonance elastography for the pancreas at 3T.Jack of many trades: Multifaceted role of neuropilins in pancreatic cancerGemcitabine treatment promotes immunosuppressive microenvironment in pancreatic tumors by supporting the infiltration, growth, and polarization of macrophages
P2860
Q27300789-5057F8CA-FB55-442B-BEAC-41BC679B7DE3Q30360377-55F424CD-C2BB-4A87-9191-6C11164F095DQ30836969-275F1C41-94B1-466C-837F-5CCA174457C6Q35585395-CDFA2AB4-FEC3-48BB-AE34-5B22208A8E0DQ37007341-81965249-39F1-4BEB-930C-8B58161D0BBDQ37455222-5A87E963-0285-4A76-99FC-39A6F1F86F1AQ37520369-9F6C5652-CBF4-4DF4-AA64-725BEB9C916BQ38638035-DDF8C291-7CC6-4F3D-8826-C909B4E020B2Q38689584-A2D0673B-3849-4AA8-B35C-D52A0C4D20D6Q38720813-E848A140-2960-4C1C-869D-D727D63F0DCBQ38971785-5B79FB43-A6B6-4631-9723-BA72725E44ECQ39039925-60F34432-5AB9-4831-935B-C6A5297BDF3AQ41228738-8CDA4366-F65B-490F-8859-D8711D17986DQ42002078-7AF91F47-02D5-4DB6-9AB0-1A27578DD07CQ47201794-219E3044-97DF-4F0D-B1C9-F95C5332B7AFQ48053117-3E7F5401-C8ED-46B3-BDA8-56EADEA26B54Q48638521-D344C8BB-F5E7-4DCF-88B3-51B3B38A0348Q49491161-E6283C74-C56E-4749-92F6-6A57530070B6Q49859674-77AA3F36-E0D3-4A54-A8F4-E8EED2CC1FFDQ51459972-B3ED1060-7CE1-43F6-92AF-0F1CFE4483DBQ53424906-40A4D1E1-6ABE-4965-BB34-734EF15D0F08Q53437917-F0D24B4C-0B91-469C-B469-CBDB132242DAQ58738114-7722654B-4C49-4F9A-B680-B1FBF3329D0CQ58790835-A57F6609-A38B-4957-BBD7-2D41750170A1
P2860
description
2014 nî lūn-bûn
@nan
2014 scientific article
@en
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
name
Desmoplasia and chemoresistance in pancreatic cancer
@ast
Desmoplasia and chemoresistance in pancreatic cancer
@en
Desmoplasia and chemoresistance in pancreatic cancer
@nl
type
label
Desmoplasia and chemoresistance in pancreatic cancer
@ast
Desmoplasia and chemoresistance in pancreatic cancer
@en
Desmoplasia and chemoresistance in pancreatic cancer
@nl
prefLabel
Desmoplasia and chemoresistance in pancreatic cancer
@ast
Desmoplasia and chemoresistance in pancreatic cancer
@en
Desmoplasia and chemoresistance in pancreatic cancer
@nl
P2093
P2860
P3181
P356
P1433
P1476
Desmoplasia and chemoresistance in pancreatic cancer
@en
P2093
Cornelius Weidenauer
Marvin Schober
Patrick Michl
Ralf Faissner
Ralf Jesenofsky
Stephan L Haas
Wolfgang Hagmann
P2860
P304
P3181
P356
10.3390/CANCERS6042137
P407
P577
2014-10-21T00:00:00Z